These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 9444968

  • 1. Dehydroepiandrosterone (DHEA) and DHEA-S interact with 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) to stimulate human osteoblastic cell differentiation.
    Scheven BA, Milne JS.
    Life Sci; 1998; 62(1):59-68. PubMed ID: 9444968
    [Abstract] [Full Text] [Related]

  • 2. The biological activities of 1alpha,25-dihydroxyvitamin D3 and its synthetic analog 1alpha,25-dihydroxy-16-ene-vitamin D3 in normal human osteoblastic cells and human osteosarcoma SaOS-2 cells are modulated by 17-beta estradiol and dependent on stage of differentiation.
    Rao LG, Liu LJ, Rawlins MR, McBroom RJ, Murray TM, Reddy GS, Uskokovic MR, Rao DS, Sutherland MK.
    Biol Pharm Bull; 2001 Mar; 24(3):242-8. PubMed ID: 11256478
    [Abstract] [Full Text] [Related]

  • 3. Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro.
    Kasperk CH, Wakley GK, Hierl T, Ziegler R.
    J Bone Miner Res; 1997 Mar; 12(3):464-71. PubMed ID: 9076590
    [Abstract] [Full Text] [Related]

  • 4. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
    Scheven BA, van der Veen MJ, Damen CA, Lafeber FP, Van Rijn HJ, Bijlsma JW, Duursma SA.
    J Bone Miner Res; 1995 Jun; 10(6):874-80. PubMed ID: 7572311
    [Abstract] [Full Text] [Related]

  • 5. Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25-dihydroxyvitamin D3 in human osteoblasts.
    Takayanagi R, Goto K, Suzuki S, Tanaka S, Shimoda S, Nawata H.
    Mech Ageing Dev; 2002 Apr 30; 123(8):1107-14. PubMed ID: 12044960
    [Abstract] [Full Text] [Related]

  • 6. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
    Sterck JG, Klein-Nulend J, Burger EH, Lips P.
    J Bone Miner Res; 1996 Mar 30; 11(3):367-76. PubMed ID: 8852947
    [Abstract] [Full Text] [Related]

  • 7. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
    Yamamoto T, Ozono K, Shima M, Yamaoka K, Okada S.
    Exp Cell Res; 1998 Oct 10; 244(1):71-6. PubMed ID: 9770350
    [Abstract] [Full Text] [Related]

  • 8. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
    van Driel M, Koedam M, Buurman CJ, Roelse M, Weyts F, Chiba H, Uitterlinden AG, Pols HA, van Leeuwen JP.
    J Cell Biochem; 2006 Oct 15; 99(3):922-35. PubMed ID: 16741965
    [Abstract] [Full Text] [Related]

  • 9. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
    van Leeuwen JP, Birkenhäger JC, van den Bemd GC, Pols HA.
    Biochim Biophys Acta; 1996 Jun 05; 1312(1):54-62. PubMed ID: 8679716
    [Abstract] [Full Text] [Related]

  • 10. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells.
    Inaba M, Terada M, Koyama H, Yoshida O, Ishimura E, Kawagishi T, Okuno Y, Nishizawa Y, Otani S, Morii H.
    J Bone Miner Res; 1995 Jul 05; 10(7):1050-6. PubMed ID: 7484280
    [Abstract] [Full Text] [Related]

  • 11. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells.
    Wang DS, Miura M, Demura H, Sato K.
    Endocrinology; 1997 Jul 05; 138(7):2953-62. PubMed ID: 9202240
    [Abstract] [Full Text] [Related]

  • 12. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
    Gómez-García L, Esbrit P, Carreño L, Sabando P, García-Flores M, Martinez ME.
    J Bone Miner Res; 2003 Jan 05; 18(1):78-87. PubMed ID: 12510808
    [Abstract] [Full Text] [Related]

  • 13. Osteoblastic NF-κB pathway is involved in 1α, 25(OH)2D3-induced osteoclast-like cells formation in vitro.
    Cong L, Zhang C, Tu G.
    Int J Clin Exp Pathol; 2015 Jan 05; 8(5):5988-96. PubMed ID: 26191332
    [Abstract] [Full Text] [Related]

  • 14. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
    Spiess YH, Price PA, Deftos JL, Manolagas SC.
    Endocrinology; 1986 Apr 05; 118(4):1340-6. PubMed ID: 3485045
    [Abstract] [Full Text] [Related]

  • 15. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
    Miyahara T, Simoura T, Osahune N, Uchida Y, Sakuma T, Nemoto N, Kozakai A, Takamura T, Yamazaki R, Higuchi S, Chiba H, Iba K, Sawada N.
    Calcif Tissue Int; 2002 Jun 05; 70(6):488-95. PubMed ID: 12016462
    [Abstract] [Full Text] [Related]

  • 16. 1,25-Dihydroxyvitamin D3 pretreatment limits prostaglandin biosynthesis by cytokine-stimulated adult human osteoblast-like cells.
    Keeting PE, Li CH, Whipkey DL, Thweatt R, Xu J, Murty M, Blaha JD, Graeber GM.
    J Cell Biochem; 1998 Feb 01; 68(2):237-46. PubMed ID: 9443079
    [Abstract] [Full Text] [Related]

  • 17. Influence of skeletal site of origin and donor age on 1,25(OH)2D3-induced response of various osteoblastic markers in human osteoblastic cells.
    Martínez ME, Medina S, Sánchez M, Del Campo MT, Esbrit P, Rodrigo A, Martínez P, Sánchez-Cabezudo MJ, Moreno I, Garcés MV, Munuera L.
    Bone; 1999 Mar 01; 24(3):203-9. PubMed ID: 10071912
    [Abstract] [Full Text] [Related]

  • 18. Effect of 1,25-dihydroxyvitamin D3 on the proliferation of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes.
    Kanatani M, Sugimoto T, Fukase M, Chihara K.
    Biochem Biophys Res Commun; 1993 Jan 29; 190(2):529-35. PubMed ID: 8427595
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
    Schedlich LJ, Muthukaruppan A, O'Han MK, Baxter RC.
    Mol Endocrinol; 2007 Oct 29; 21(10):2378-90. PubMed ID: 17595320
    [Abstract] [Full Text] [Related]

  • 20. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
    Pernalete N, Mori T, Nishii Y, Slatopolsky E, Brown AJ.
    Endocrinology; 1991 Aug 29; 129(2):778-84. PubMed ID: 1649745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.